FDA Investigator: Kara A. Scheibner

- Kara A. Scheibner first started conducting FDA inspections in 2017, with the last inspection in 2024. Over that time, Kara A. Scheibner has conducted 25 inspections at 25 companies across 25 sites.

Get Kara Scheibner's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Armstrong Pharmaceuticals, Inc., Canton | 2024

Out-of-stock
Kara A. Scheibner
Human Drugs Form 483

FDA 483 Sitec Labs Limited, Navi Mumbai | 2024

Out-of-stock
Kara A. Scheibner
Human Drugs Form 483

FDA 483 Solvias AG, Kaiseraugst | 2023

Out-of-stock
Kara A. Scheibner
Human Drugs Form 483

FDA 483 Raptim Research Pvt. Ltd., Navi Mumbai | 2023

Out-of-stock
Kara A. Scheibner
Human Drugs Form 483

FDA 483 Synchron Research Services Pvt. Ltd., Ahmedabad | 2019

Out-of-stock
Kara A. Scheibner
Human Drug Form 483

FDA 483 Charles River Laboratories Ashland, LLC, Skokie | 2019

Out-of-stock
Kara A. Scheibner
Human Drug Form 483

FDA 483 Keystone Bioanalytical, Inc., North Wales | 2019

Out-of-stock
Kara A. Scheibner
Human Drug Form 483

FDA 483 Raptim Research Ltd, Navi Mumbai | 2019

Out-of-stock
Kara A. Scheibner
Human Drug Form 483

FDA 483 Dana-Farber Harvard Cancer Center, Boston | 2018

Out-of-stock
Kara A. Scheibner
Human Drug Form 483

FDA 483 inVentiv Health Clinical Lab, Inc., Princeton | 2017

Out-of-stock
Kara A. Scheibner
Human Drug Form 483